These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 18718989

  • 1. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA.
    Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
    [Abstract] [Full Text] [Related]

  • 2. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 3. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G.
    Ann N Y Acad Sci; 2009 Sep 02; 1173():47-51. PubMed ID: 19758131
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.
    Lupus; 2011 Jan 02; 20(1):28-34. PubMed ID: 20943718
    [Abstract] [Full Text] [Related]

  • 6. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 02; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.
    Lupus; 2011 Oct 02; 20(12):1267-74. PubMed ID: 21813587
    [Abstract] [Full Text] [Related]

  • 8. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 02; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis.
    Heidenreich U, Mayer G, Herold M, Klotz W, Stempfl Al-Jazrawi K, Lhotta K.
    Lupus; 2009 Dec 02; 18(14):1276-80. PubMed ID: 19854810
    [Abstract] [Full Text] [Related]

  • 10. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Dec 02; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 02; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 12. Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?
    Esdaile JM, Joseph L, Abrahamowicz M, Li Y, Danoff D, Clarke AE.
    J Rheumatol; 1996 Nov 02; 23(11):1891-6. PubMed ID: 8923362
    [Abstract] [Full Text] [Related]

  • 13. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Nephrol Dial Transplant; 2012 Sep 02; 27(9):3552-9. PubMed ID: 22700716
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.
    Grootscholten C, Dieker JW, McGrath FD, Roos A, Derksen RH, van der Vlag J, Daha MR, Berden JH.
    Ann Rheum Dis; 2007 May 02; 66(5):693-6. PubMed ID: 17135217
    [Abstract] [Full Text] [Related]

  • 17. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC, Ho LY, Leung HW, Wong LG.
    Transl Res; 2010 Dec 02; 156(6):320-5. PubMed ID: 21078493
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.
    J Rheumatol; 2006 Apr 02; 33(4):695-7. PubMed ID: 16583471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.